No paralogue variants have been mapped to residue 270 for KCNQ1.
KCNQ1 | HVDRQGGTWRLLGSVVFIHRQELITTLYIG>F<LGLIFSSYFVYLAEKDAVN-----ESGRVE | 295 |
KCNQ2 | RMDRRGGTWKLLGSVVYAHSKELVTAWYIG>F<LCLILASFLVYLAEKGE----------NDH | 260 |
KCNQ3 | RMDRRGGTWKLLGSAICAHSKELITAWYIG>F<LTLILSSFLVYLVEKDVPEVDAQGEEMKEE | 299 |
KCNQ4 | RMDRRGGTWKLLGSVVYAHSKELITAWYIG>F<LVLIFASFLVYLAEKDA----------NSD | 266 |
KCNQ5 | RMDRRGGTWKLLGSVVYAHSKELITAWYIG>F<LVLIFSSFLVYLVEKDA----------NKE | 294 |
KCNA1 | KLSRHSKGLQILGQTLKASMRELGLLIFFL>F<IGVILFSSAVYFAEAEE---------AESH | 355 |
KCNA10 | KLSRHSKGLQILGQTLKASMRELGLLIFFL>F<IGVILFSSAVYFAEVDE---------PESH | 404 |
KCNA2 | KLSRHSKGLQILGQTLKASMRELGLLIFFL>F<IGVILFSSAVYFAEADE---------RESQ | 357 |
KCNA3 | KLSRHSKGLQILGQTLKASMRELGLLIFFL>F<IGVILFSSAVYFAEADD---------PTSG | 427 |
KCNA4 | KLSRHSKGLQILGHTLRASMRELGLLIFFL>F<IGVILFSSAVYFAEADE---------PTTH | 507 |
KCNA5 | KLSRHSKGLQILGKTLQASMRELGLLIFFL>F<IGVILFSSAVYFAEADN---------QGTH | 463 |
KCNA6 | KLSRHSKGLQILGKTLQASMRELGLLIFFL>F<IGVILFSSAVYFAEADD---------DDSL | 405 |
KCNA7 | KLSRHSKGLQILGQTLRASMRELGLLIFFL>F<IGVVLFSSAVYFAEVDR---------VDSH | 341 |
KCNB1 | KLARHSTGLQSLGFTLRRSYNELGLLILFL>A<MGIMIFSSLVFFAEKDE---------DDTK | 360 |
KCNB2 | KLARHSTGLQSLGFTLRRSYNELGLLILFL>A<MGIMIFSSLVFFAEKDE---------DATK | 364 |
KCNC1 | KLTRHFVGLRVLGHTLRASTNEFLLLIIFL>A<LGVLIFATMIYYAERIGAQPNDPSASEHTH | 383 |
KCNC2 | KLTRHFVGLRVLGHTLRASTNEFLLLIIFL>A<LGVLIFATMIYYAERVGAQPNDPSASEHTQ | 420 |
KCNC3 | KLTRHFVGLRVLGHTLRASTNEFLLLIIFL>A<LGVLIFATMIYYAERIGADPDDILGSNHTY | 486 |
KCNC4 | KLTRHFVGLRVLGHTLRASTNEFLLLIIFL>A<LGVLIFATMIYYAERIGARPSDPRGNDHTD | 419 |
KCND1 | KFSRHSQGLRILGYTLKSCASELGFLLFSL>T<MAIIIFATVMFYAEKGT---------NKTN | 355 |
KCND2 | KFSRHSQGLRILGYTLKSCASELGFLLFSL>T<MAIIIFATVMFYAEKGS---------SASK | 353 |
KCND3 | KFSRHSQGLRILGYTLKSCASELGFLLFSL>T<MAIIIFATVMFYAEKGS---------SASK | 350 |
KCNF1 | KLARHSSGLQTLTYALKRSFKELGLLLMYL>A<VGIFVFSALGYTMEQSH---------PETL | 353 |
KCNG1 | RLARHSLGLQTLGLTARRCTREFGLLLLFL>C<VAIALFAPLLYVIENEM-----A---DSPE | 407 |
KCNG2 | RLARHSLGLRSLGLTMRRCAREFGLLLLFL>C<VAMALFAPLVHLAEREL-----G---ARRD | 352 |
KCNG3 | KLARHFIGLQTLGLTLKRCYREMVMLLVFI>C<VAMAIFSALSQLLEHGL-----DLETSNKD | 356 |
KCNG4 | RLARHSLGLQTLGLTVRRCTREFGLLLLFL>A<VAITLFSPLVYVAEKES-----G---RVLE | 401 |
KCNS1 | KLARHSTGLRSLGATLKHSYREVGILLLYL>A<VGVSVFSGVAYTAEKEE----------DVG | 404 |
KCNS2 | KLARHSTGLRSLGATLKYSYKEVGLLLLYL>S<VGISIFSVVAYTIEKEE----------NEG | 357 |
KCNS3 | KLARHSVGLRSLGATLRHSYHEVGLLLLFL>S<VGISIFSVLIYSVEKDD---------HTSS | 353 |
KCNV1 | KLGRHSTGLRSLGMTITQCYEEVGLLLLFL>S<VGISIFSTVEYFAEQSI---------PDTT | 375 |
KCNV2 | KLARHSTGLRAFGFTLRQCYQQVGCLLLFI>A<MGIFTFSAAVYSVEHDV---------PSTN | 440 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.F270S | c.809T>C | Putative Benign | SIFT: Polyphen: |